Search results
5 Things to Know: COVID-19 Vaccines for Immunocompromised People
Medscape· 5 days agoCDC experts share what clinicians should know about COVID-19 prevention in immunocompromised...
Does COVID-19 Persist?
MedPage Today· 1 day agoWith 17 million adults reporting long COVID symptoms like brain fog and fatigue, the idea of viral persistence has gained traction. "At the beginning of...
Sanofi to make €1bn biomanufacturing investment in France
Pharmaceutical Technology via Yahoo Finance· 7 days agoSanofi plans to invest €1bn in Vitry-sur-Seine to construct a new unit in a bid to double the ...
What to know about the COVID-19 FLiRT variant as it spreads in Connecticut ahead of summer
The News-Times· 6 days agoA new group of COVID-19 variants called “FLiRT” are rapidly becoming the dominant mutations of the...
Mirikizumab Shows Promise for Moderate to Severe Crohn's
Medscape· 1 day agoAlready approved for ulcerative colitis, the monoclonal antibody mirikizumab met study endpoints for...
Earnings call: Dyadic International Eyes Growth in Health and Proteins
Investing.com· 3 days agoDyadic International has made notable progress in the human health sector, particularly with its ...
Press Release: Dupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at...
Benzinga· 12 hours agoDupixent® late-breaking data from NOTUS confirmatory phase 3 COPD study presented at ATS and published in NEJM NOTUS results confirm landmark data from the phase 3 BOREAS study and show Dupixent significantly
HaemaLogiX welcomes former Australian Federal Minister for Health Professor the Hon Greg Hunt to the...
WPRI Providence· 21 hours agoFederal Minister for Health, to the HaemaLogiX Board as a Non-Executive Director. This appointment marks the first corporate directorship that Prof Hunt has accepted since completing his period ...
Critics Say FDA's Use of Surrogate Markers Falling Short
Medscape· 4 days agoAs the FDA's use of surrogate endpoints in the drug approval process is increasing, researchers are...
KeyBanc maintains overweight rating on ABCL stock By Investing.com
Investing.com· 5 days agoOn Thursday, KeyBanc Capital Markets reaffirmed its positive stance on AbCellera Biologics...